ABC | Volume 113, Nº4, Outubro 2019

Atualização Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(4):787-891 288. Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S. Suicidal behavior and depression in smoking cessation treatments. PloS One. 2011;6(11):e27016. 289. Issa JS, Abe TO, Moura S, Santos PC, Pereira AC. Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting. Nicotine Tob Res. 2013;15(6):1146-50. 290. Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007072. 291. Calantzopoulos A. Politico. Open letter from Philip Morris International CEO [Cited in 2019 Mar 31]. Available from: https://www.politico.eu/ sponsored-content/open-letter-from-philip-morris-international-ceo/. 292. Benowitz NL, Burbank, AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515-23. 293. World Health Organization. (WHO) [Internet]. Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ ENNDS): Report by WHO. In: Conference of the Parties to the WHO Framework Convention on Tobacco Control, Seventh Session. 2016 nov 07-12; Delhi, India [Cited in 2019 mar 31]. Available from: https://www. who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf. 294. World Health Organization. (WHO). WHO Study Group on Tobacco Product Regulation (TobReg). AdvisoryNote.Waterpipe tobacco smoking: health effects, research needs and recommended actions by regulators. Geneva; 2005. 295. Jacob P 3rd, Abu Raddaha AH, Dempsey D, Havel C, Peng M, Yu L, et al. Nicotine, carbonmonoxide, and carcinogen exposure after a single use of a water pipe. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2345-53. 296. Morton J, Song Y, Fouad H, Awa FE, Abou El Naga R, et al. Cross-country comparison of waterpipe use: nationally representative data from 13 low and middle-income countries from the Global Adult Tobacco Survey (GATS). Tob Control. 2014;23(5):419-27. 297. Menezes AM, WehrmeisterI FC, HortaI BL, Szwarcwald CL, Vieira ML, Malta DC. Frequency of the use of hookah among adults and its distribution according to sociodemographic characteristics, urban or rural area and federative units: National Health Survey, 2013. Rev Bras Epidemiol. 2015;18(Suppl 2):57-67. 298. Loh WY, Piper ME, Schlam TR, Fiore MC, Smith SS, Jorenby DE, et al. Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res. 2012;14(2):131-41. 299. Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Mottillo S, Joseph L, et al. Pharmacotherapies for smoking cessation: ameta-analysis of randomized controlled trials. CMAJ. 2008;179(2):135-44. 300. Oliveira GMM, Mendes M, Dutra OP, Achutti A, Fernandes M, Azevedo V, et al. 2019: Recommendations for Reducing Tobacco Consumption in Portuguese-Speaking Countries - Positioning of the Federation of Portuguese Language Cardiology Societies. Arq Bras Cardiol. 2019;112(4):477-86. 301. Ding D. Surveillance of global physical activity: progress, evidence, and future directions. Lancet Glob Health. 2018;6(10):e1046-7. 302. Guthold R, Stevens GA, Riley LM, Bull FC.Worldwide trends in insufficient physical activity from2001 to 2016: a pooled analysis of 358 population- based surveys with 1.9 million participants. Lancet Glob Health. 2018;6(10):e1077-86. 303. Powell KE, Paluch AE, Blair SN. Physical activity for health: What kind? Howmuch? How intense? On top of what? Annu Rev PublicHealth. 2011 Dec;32:349-65. 304. Arem H, Moore SC, Patel A, Hartge P, Gonzalez AB, Visvanathan K, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA InternMed. 2015;175(6):959-67. 305. De Ferrari GM, Dusi V, Ruffinazzi M, Gionti V, Cacciavillani L, Noussan P, et al. Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillatton. J Am Coll Cardiol. 2019;73(16):2117-8. 306. Saint-Maurice PF, Coughlan D, Kelly SP, Keadle SK, CookMB, Carlson SA, et al. Association of Leisure-Time Physical Activity Across the Adult Life Course With All-Cause and Cause-Specific Mortality. JAMA NetwOpen. 2019;2(3):e190355. 307. Stamatakis E, Gale J, Bauman A, Ekelund U, Hamer M, Ding D. Sitting time, physical activity, and risk of mortality in adults. J Am Coll Cardiol. 2019;73(16):2062-72. 308. Araújo CGS. Quantificando na consulta médica o padrão de exercício físico e de esporte do paciente. Rev DERC. 2013;19(1):24-5. 309. Bangsbo J, Blackwell J, Boraxbekk CJ, Caserotti P, Dela F, Adam B, et al. CopenhagenConsensus statement:physical activity and ageing. Br JSports Med. 2019 Feb. pii: bjsports-2018-100451. [Epub ahead of print] 310. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126-31. 311. Brito LB, Ricardo DR, Araujo DS, Ramos PS, Myers J, Araujo CG. Ability to sit and rise from the floor as a predictor of all-cause mortality. Eur J Prev Cardiol. 2014;21(7):892-8. 312. Kokkinos P, Myers J, Faselis C, Panagiotakos DB, Doumas M, Pittaras A, et al. Exercise capacity andmortality in older men: a 20-year follow-up study. Circulation. 2010;122(8):790-7. 313. Laukkanen JA, Makikallio TH, Rauramaa R, Kiviniemi V, Ronkainen K, Kurl S. Cardiorespiratory fitness is related to the risk of sudden cardiac death: a population-based follow-up study. J Am Coll Cardiol. 2010;56(18):1476-83. 314. Laukkanen JA, Kujala UM. Low cardiorespiratory fitness Is a risk factor for death: exercise intervention may lower mortality? J Am Coll Cardiol. 2018;72(19):2293-6. 315. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801. 316. Metter EJ, Talbot LA, Schrager M, Conwit RA. Arm-crankingmuscle power and arm isometricmuscle strength are independent predictors of all-cause mortality in men. J Appl Physiol (1985). 2004;96(2):814-21. 317. Yang J, Christophi CA, Farioli A, Baur DM, Moffatt S, Zollinger TW, et al. AssociationBetweenPush-upExerciseCapacityandFutureCardiovascular Events Among Active Adult Men. JAMANetwOpen. 2019;2(2):e188341. 318. World Health Organization. (WHO). Guidelines Approved by the Guidelines ReviewCommittee. Guidelines on physical activity, sedentary behaviour and sleep for children under 5 years of age. Geneva; 2019. 319. BalassianoDH, Araujo CG. Maximal heart rate: influence of sport practice during childhood and adolescence. Arq Bras Cardiol. 2013;100(4):333-8. 320. Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L. The acute versus the chronic response to exercise. Med Sci Sports Exerc. 2001;33(6 Suppl):S438-45; discussion S52-3. 321. Blair SN, Kohl HW, Barlow CE, Paffenbarger Jr RS, Gibbons LW, Macera CA. Changes in physical fitness and all-causemortality. Aprospective study of healthy and unhealthy men. JAMA. 1995;273(14):1093-8. 322. Eriksson JG, Kajantie E, Lampl M, Osmond C, Barker DJ. Markers of biological fitness as predictors of all-cause mortality. Ann Med. 2013;45(2):156-61. 323. Araújo CG, Castro CL, Franca JF, Araújo DS. Sitting–rising test: Sex- and age-reference scores derived from 6141 adults. Eur J Prev Cardiol. 2019 May:2047487319847004. [Epub ahead of print] 324. Araujo CG, Carvalho T, Castro CL, Costa RV, Moraes RS, Oliveira Filho JA, et al. Normatização dos equipamentos e técnicas da reabilitação cardiovascular supervisionada. Arq Bras Cardiol. 2004;83(5):448-52. 881